ArticleMolecular pharmacology2025

Inhibition of constitutive activity of the atypical chemokine receptor 3 by the small-molecule inverse agonist VUF16840.

Reggie Bosma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.